Advertisement
US Splashes $119,000,000 On Monkeypox Vaccines.
American authorities have rushed to secure a series of contracts for vaccines against monkeypox that could reach 13 million doses and up to $299 million if all options are exercised.
Danish pharma company Bavarian Nordic will provide the first batch of jabs - which were originally designed to tackle smallpox but have since been approved for monkeypox. Bavarian Nordic also announced a similar agreement with an undisclosed European country, with the vaccines not due to arrive till 2023.
MonkeyPox
Washington also bought $7.5-million worth of antiviral monkeypox treatment tecovirimat.
